122 related articles for article (PubMed ID: 21259246)
1. Delay in treatment of early-stage hepatocellular carcinoma using radiofrequency ablation may impact survival of cirrhotic patients in a surveillance program.
Chen WT; Fernandes ML; Lin CC; Lin SM
J Surg Oncol; 2011 Feb; 103(2):133-9. PubMed ID: 21259246
[TBL] [Abstract][Full Text] [Related]
2. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
Raut CP; Izzo F; Marra P; Ellis LM; Vauthey JN; Cremona F; Vallone P; Mastro A; Fornage BD; Curley SA
Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma.
Nicoli N; Casaril A; Marchiori L; Mangiante G; Marini G; Colombari R; Portuese A; Hasheminia AR
Chir Ital; 2000; 52(1):29-40. PubMed ID: 10832524
[TBL] [Abstract][Full Text] [Related]
4. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
5. [Radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis].
Bonny C; Abergel A; Gayard P; Chouzet S; Ughetto S; Slim K; Rosenfeld L; Guillon R; Poincloux L; Bommelaer G
Gastroenterol Clin Biol; 2002; 26(8-9):735-41. PubMed ID: 12434078
[TBL] [Abstract][Full Text] [Related]
6. Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis.
Santambrogio R; Opocher E; Zuin M; Selmi C; Bertolini E; Costa M; Conti M; Montorsi M
Ann Surg Oncol; 2009 Dec; 16(12):3289-98. PubMed ID: 19727960
[TBL] [Abstract][Full Text] [Related]
7. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
8. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.
Takahashi S; Kudo M; Chung H; Inoue T; Nagashima M; Kitai S; Tatsumi C; Minami Y; Ueshima K; Fukunaga T; Haji S
Dig Dis; 2007; 25(4):303-9. PubMed ID: 17960064
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients.
Guglielmi A; Ruzzenente A; Battocchia A; Tonon A; Fracastoro G; Cordiano C
Hepatogastroenterology; 2003; 50(50):480-4. PubMed ID: 12749252
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
12. [Radiofrequency ablation: a new approach in the treatment of hepatocellular carcinoma].
Crucinio N; Palieri AP; Nacchiero MC; Cela EM; Muscatiello N; Sgarro C; Faleo D
G Chir; 2001 Mar; 22(3):89-92. PubMed ID: 11284172
[TBL] [Abstract][Full Text] [Related]
13. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy.
Choi D; Lim HK; Kim MJ; Lee SH; Kim SH; Lee WJ; Lim JH; Joh JW; Kim YI
Radiology; 2004 Jan; 230(1):135-41. PubMed ID: 14631050
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients.
Li WH; Ma KW; Cheng M; Chui KH; Chan PT; Chu WH; Fung HS; Kowk CH; Cheung MT
ANZ J Surg; 2010 Oct; 80(10):714-21. PubMed ID: 21040332
[TBL] [Abstract][Full Text] [Related]
17. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
[TBL] [Abstract][Full Text] [Related]
18. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW
Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency-assisted liver resection in cirrhotic patients with hepatocellular carcinoma.
Curro G; Jiao L; Scisca C; Baccarani U; Mucciardi M; Habib N; Navarra G
J Surg Oncol; 2008 Nov; 98(6):407-10. PubMed ID: 18683211
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
Komorizono Y; Oketani M; Sako K; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Ishibashi K; Arima T
Cancer; 2003 Mar; 97(5):1253-62. PubMed ID: 12599233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]